Transient insomnia: hypnotic therapy can be indicated ... category B of the US FDA classification as regards the risk of drug use in pregnant women (its use is allowed in low-risk situations).
Eisai has launched its insomnia drug Dayvigo in Japan ... Eisai also has aspirations to extend the use of Dayvigo into new areas, including in dementia to reduce night-time wandering and falls ...
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.
Antidepressants are prescription medications used to treat major depressive disorder (MDD, depression), a common mental health condition that can make you feel sad, worried, and hopeless and can ...